February 27, 2018 / 6:51 AM / 6 months ago

BRIEF-Irlab Therapeutics Q4 Operating Loss At SEK 13 Million

Feb 27 (Reuters) - Irlab Therapeutics Ab:

* PROPOSES NO DIVIDEND FOR 2017

* Q4 OPERATING LOSS AT SEK 13 MILLION VERSUS LOSS SEK 14.6 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below